HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy

NCT06844669 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped Futility

Conditions

HER2-positive Breast Cancer
HER2+ Breast Cancer

Interventions

DRUG: Carvedilol
DRUG: Empagliflozin

Sponsor

Washington University School of Medicine